What are the potential interactions between sertraline (selective serotonin reuptake inhibitor) and metoprolol (beta-blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sertraline and Metoprolol Drug Interactions

Sertraline has minimal interaction with metoprolol compared to other SSRIs, making it a safer choice when both medications are needed. 1

Pharmacokinetic Interaction Mechanism

The primary interaction between SSRIs and metoprolol occurs through the cytochrome P450 2D6 (CYP2D6) enzyme system:

  • Metoprolol is primarily metabolized by CYP2D6 enzyme 1
  • Different SSRIs inhibit CYP2D6 to varying degrees, affecting metoprolol metabolism 1
  • Inhibition of CYP2D6 leads to increased plasma concentrations of metoprolol, potentially causing enhanced beta-blockade effects 2

Severity of Interaction by SSRI Type

High-Risk SSRIs (Avoid with Metoprolol)

  • Paroxetine: Increases metoprolol bioavailability 4-6 fold 1
  • Fluoxetine: Similar potent CYP2D6 inhibition as paroxetine 1
  • Bupropion: Strong CYP2D6 inhibitor with significant interaction potential 1

Moderate-Risk SSRIs (Use with Caution)

  • Escitalopram: 2-3 fold increase in metoprolol bioavailability 1
  • Citalopram: 2-3 fold increase in metoprolol bioavailability 1
  • Duloxetine: Moderate CYP2D6 inhibition 1

Low-Risk Options (Preferred)

  • Sertraline: Inhibits CYP2D6 to little or no extent; considered safe with metoprolol 1
  • Venlafaxine: Minimal CYP2D6 inhibition 1
  • Mirtazapine: Minimal CYP2D6 inhibition 1
  • Mianserin: Minimal CYP2D6 inhibition 1

Clinical Consequences of Interaction

When significant interaction occurs, patients may experience:

  • Hypotension
  • Bradycardia
  • Atrioventricular block
  • Increased risk of falls
  • Increased risk of hospitalization or emergency department visits 2

A 2020 study found that patients receiving beta-blockers with potent CYP2D6-inhibiting antidepressants had a 53% higher risk of hospitalization or ED visits for hemodynamic events compared to those not on antidepressants (HR 1.53,95% CI 1.03-2.81) 2.

Risk Factors for Severe Interactions

Certain patient factors increase the risk of clinically significant interactions:

  • Advanced age
  • Male sex
  • Higher beta-blocker doses
  • African American race or Hispanic ethnicity 2

Management Recommendations

  1. First-line approach: Choose sertraline when an SSRI is needed for a patient on metoprolol 1

  2. If using moderate-risk SSRIs (citalopram, escitalopram, duloxetine):

    • Consider reducing metoprolol dose
    • Monitor more closely for bradycardia and hypotension 1
  3. Avoid high-risk combinations:

    • Do not use paroxetine, fluoxetine, or bupropion concurrently with metoprolol due to extensive interactions and risk of serious adverse effects 1
  4. Monitoring parameters when both drugs are necessary:

    • Heart rate and blood pressure
    • Signs of excessive beta-blockade (fatigue, dizziness, hypotension)
    • Symptoms of bradycardia or heart block

Special Considerations

  • Extended-release metoprolol formulations (metoprolol succinate) provide more consistent plasma concentrations 3, which may help minimize peak concentration-related side effects when interaction occurs
  • Patients with heart failure on metoprolol require particularly careful monitoring if an SSRI is added, as bradycardia could worsen cardiac output 4

By selecting sertraline over other SSRIs when metoprolol therapy is necessary, clinicians can minimize the risk of potentially serious drug interactions while effectively treating both conditions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.